Update on Severe Asthma 2026

  • Continuing Education
female taking her inhaler.

-

Registration Deadline: March 13

Elevate your expertise in severe asthma by engaging with a multidisciplinary, two-day hybrid course that explores cutting-edge assessment strategies, emerging treatments, and complex comorbidities across pediatric and adult populations. Gain practical insights through in-depth lectures, guideline updates, and case-based discussions designed for clinicians dedicated to advancing asthma care.

  • Live Online or In Person

This course is taught online or in person.

Simmons College | 300 Fenway, Boston MA 02115

$275 Save with early registration

For a full list of profession pricing see below.
View All

Fee increases to $350 after

Continuing Education

Earn up to:
23.00 AMA PRA Category 1 Credit(s) ™
View All

Please view the Schedule for a full description of the program.

On This Page

Overview

Assessment and management of severe asthma are issues currently at the forefront of modern asthma investigation and care. This two-day, live, hybrid (in-person and on-line) course will provide insights from a multidisciplinary team representing the Severe Asthma Program at Brigham and Women’s Hospital. Our focus will include both pediatric and adult patients with asthma. We will devote one day to assessment of severe asthma and complicating illnesses and one day to its treatment, including novel approaches to management. Lectures will cover topics in the immunology and genetics of severe asthma; aspirin-exacerbated respiratory disease; eosinophilic lung diseases including allergic bronchopulmonary aspergillosis, occupational asthma, obesity and asthma, and special considerations in school-age children. Presentations on the contribution of gastroesophageal reflux disease, upper airway obstruction, and sinusitis/nasal polyposis will be given by a gastroenterologist, voice specialist, and otolaryngologist, respectively. We will focus on the treatment of asthma, including recent GINA and NAEPP Guidelines, modern biologics, and novel therapies in development. We will review in depth our protocol for the evaluation of severe asthma and have opportunity to discuss interesting cases of severe asthma. This course is appropriate for allergists, pulmonologists, and other specialists with an interest in the management of severe asthma. 

Learning Objectives

  • Systematically evaluate difficult-to-control asthma.
  • Identify specific severe asthma phenotypes/endotypes.
  • Utilize novel asthma therapeutics with confidence.

Developed and Offered By:

  • Brigham and Women's Hospital logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Brigham and Women's Hospital.

Who Should Participate

Pulmonary Medicine, Allergy and Immunology, Internal Medicine, Otolaryngology

Schedule

All agenda sessions are in Eastern Time.

Day 1

Monday, March 16, 2026

Product Theatre with breakfast provided

7:30-8:30 am

Welcome and Introduction

Elliot Israel

8:30-8:35 am

“Can’t Miss Articles” in Severe Asthma

8:35-9:00 am

Asthma Genetics and the Environment in Severe Asthma

Benjamin Raby

9:00-9:40 am

Diagnostic Assessment of Severe Asthma

Nora Barrett

9:40-10:20 am

Break

10:20-10:30 am

Towards an Understanding of Type-2-Low Asthma

Bruce Levy

10:30-11:10 am

Is the Primary Prevention of Asthma in Sight? Presentations and Round-Table Discussion

Wanda Phipatanakul; Scott Weiss; Peggy Lai

11:10-11:55 am

Occupational Exposures and Severe Asthma

11:55 am-12:30 pm

Product Theatre with lunch provided

12:30-1:30 pm

Asthma Insights: The View from the Airways

Benjamin Medoff

1:30-2:10 pm

Break

2:10-2:20 pm

Diagnostic Considerations in Children with Severe Asthma

Ben Nelson

2:20-2:55 pm

Bronchiectasies and Asthma : Is There an Overlap?

2:55-3:30 pm

Guest Lecture: Precision Medicine Approaches to Severe Asthma: Lessons from the PreCISE Trial

Steve Georas

3:30-4:15 pm

Interactive Case Discussions

Elliot Israel; Benjamin Medoff; Ayobami Akenroye

4:15-5:00 pm

Day 2

Tuesday, March 17, 2026

Product Theatre with breakfast provided

7:30-8:30 am

The "Next Big Thing" in Severe Asthma - What May Lie Ahead

8:30-9:00 am

Choosing Among the Biologics for Severe Asthma

Elliot Israel

9:00-9:40 am

Clinical Remission in Asthma: What is it? Is it an Achievable Goal of Therapy?

9:40-10:20 am

Break

10:20-10:30 am

Asthma, Anxiety, and Depression

10:30-11:10 am

Eosinophilic Lung Disease and Asthma

Joshua Boyce

11:10-11:50 am

Guest Lecture: Managing Severe Asthma in Children

11:50 am-12:30 pm

Product Theatre with lunch provided

12:30-1:30 pm

Obesity, Diabetes, and Asthma

Dinah Foer

1:30-2:10 pm

Cigarette Smoking, COPD, and Chronic Obstructive Asthma

Craig Hersh

2:10-2:50 pm

Break

2:50-3:00 pm

"Anti-Inflammatory Rescue": Options and Challenges

Nancy Lange-Vaidya

3:00-3:40 pm

Severe Asthma, the Biologics, and Population Health Management

3:40-4:15 pm

Case Discussions

Elliot Israel; Nancy Lange-Vaidya; Ayobami Akenroye

4:15-5:00 pm

Pre-Recorded Lectures

Asthma Mimics: Consider TracheobronchomalaciaA. El-Boueiz & M. Shafiq
New Recommendations for the Interpretation of PFTsN. Lange-Vaidya
Airway Oscillometry in Adults and Very Young ChildrenA. El-Boueiz, P. Moschovis
Exercise-Induced AsthmaT. B. Kinane
Gastroesophageal Reflux and Severe AsthmaC. Velez
Laryngeal Disordered Breathing Mimicking Severe AsthmaT. Carroll & L. Gordon
Treating Rhinosinusitis and Nasal Polyposis A. Maxfield
Occupational Exposures and Severe AsthmaR. Mccunney

 

                                                                                   

                                  

                                                                          

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

 

Course Directors

Nora Barrett, MD
Associate Professor of Medicine, Brigham and Women's Hospital

Joshua Boyce, MD
Albert L. Sheffer Professor of Medicine in the Field of Allergic Disease, Brigham and Women's Hospital

Thomas Carroll, MD
Associate Professor of Otolaryngology Head and Neck Surgery, Brigham and Women's Hospital

James Chalmers, MBChB, PhD, FRCPE, FERS
Professor of Respiratory Medicine and Gastroenterology, University of Dundee School of Medicine

Adel El Boueiz, MD
Assistant Professor of Medicine, Brigham and Women's Hospital

Chris Fanta, MD
Professor of Medicine, Brigham and Women's Hospital

Dinah Foer, MD
Assistant Professor of Medicine, Brigham and Women's Hospital

Steve Georas
Professor of Medicine, Environmental Medicine, Microbiology and Immunology, University of Rochester Medical Center

Lindsey Gordon, CCC-SLP
Speech Language Pathologist, Brigham and Women's Hospital

Craig Hersh, MD
Professor of Medicine, Brigham and Women's Hospital

T. Bernard Kinane, MBChB, MD
Professor of Clinical Pediatrics, Massachusetts General Hospital

Peggy Lai, MD, MPH
Associate Professor of Medicine, Massachusetts General Hospital

Tanya Laidlaw, MD
Associate Professor of Medicine, Brigham and Women's Hospital

Bruce Levy, MD
Hersey Professor of the Theory and Practice of Physic, Harvard Medical School

Alice Maxfield, MD
Assistant Professor of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital

Peter Moschovis, MD, MPH
Assistant Professor of Pediatrics, Massachusetts General Hospital

Kari Nadeau MD, PhD
Chair, Department of Environmental Health, Harvard T.H. Chan School of Public Health

Ben Nelson, MD
Assistant Professor of Pediatrics, Massachusetts General Hospital

Ian Pavord, DM, FRCP, FERS, FMedSci
Professor of Respiratory Medicine, University of Oxford

Wanda Phipatanakul, MD
S. Jean Emans, MD, Professor of Pediatrics, Boston Children's Hospital

Benjamin Raby, MD, MPH
Leila and Irving Perlmutter Professor of Pediatrics, Boston Children's Hospital

Sejal Saglani, MD, FRCPCH, FMedSci
Professor of Pediatric Respiratory Medicine, Imperial College London

Majid Shafiq, MD, MPH
Associate Professor of Medicine, Brigham and Women's Hospital

Christopher Velez, MD
Assistant Professor of Medicine, Massachusetts General Hospital

Scott Weiss, MD
Professor of Medicine, Brigham and Women's Hospital

Complete Your Registration

Started a registration? Log in to enroll today.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Fee Disclaimer

You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus. Recordings will be available for 60 days after the course has ended. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. 

Review the cancellation policy.

Early Registration Deadline:

Role Course Fee Early Registration Course Fee
Physician (MD/DO) $350.00 $275.00
Nurse (RN/APRN) $275.00 $200.00
PA $275.00 $200.00
Psychologist $275.00 $200.00
Resident/Fellow $150.00 $75.00
Social Worker $275.00 $200.00
Student $100.00 $25.00
Allied Health Professional / Other $275.00 $200.00

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Harvard Medical School designates this live activity for a maximum of 23.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept  AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. 

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. 

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Work in Interdisciplinary Teams
  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-Based Learning and Improvement

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.